Structure Therapeutics (GPCR) Total Current Liabilities (2022 - 2026)

Structure Therapeutics' Total Current Liabilities history runs 5 years deep, the most recent figure standing at $57.0 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 56.18% year-over-year to $57.0 million; the TTM figure through Mar 2026 stood at $57.0 million (up 56.18% YoY), while the FY2025 annual figure was $63.3 million, up 75.69% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $57.0 million, down from $63.3 million in the prior quarter.
• The five-year high for Total Current Liabilities was $63.3 million in Q4 2025, with the low at $11.0 million in Q1 2023.
• The 5-year median for Total Current Liabilities is $29.1 million (2023), against an average of $32.3 million.
• Peak annual rise in Total Current Liabilities reached 114.38% in 2024, while the deepest fall reached 45.6% in 2024.
• Structure Therapeutics' Total Current Liabilities stood at $13.0 million in 2022, then jumped by 90.16% to $24.7 million in 2023, then soared by 45.6% to $36.0 million in 2024, then surged by 75.69% to $63.3 million in 2025, then declined by 9.96% to $57.0 million in 2026.
• Business Quant data shows GPCR's Total Current Liabilities at $57.0 million in Q1 2026, $63.3 million in Q4 2025, and $57.5 million in Q3 2025.